Fibromyalgia creates widespread musculoskeletal pain, profound fatigue, and cognitive difficulties that persist despite conventional treatment approaches. At Mend The Mind, we provide specialized ketamine therapy for fibromyalgia as part of a comprehensive, multi-modal treatment approach. Our protocols address the central sensitization and nervous system dysregulation underlying fibromyalgia symptoms, combining anesthesia-level medical expertise with body-centered therapeutic support.
Fibromyalgia requires honest, realistic treatment approaches that recognize both the potential benefits and limitations of available interventions. Ketamine therapy shows promise for some patients with treatment-resistant fibromyalgia, though research indicates variable results and the need for ongoing treatment to maintain benefits. We approach fibromyalgia care with transparency about what ketamine can and cannot achieve.
Fibromyalgia affects 1-5% of the population, causing widespread chronic musculoskeletal pain without clear physical injury or laboratory abnormalities. Unlike pain from tissue damage or inflammation, fibromyalgia pain arises from altered pain processing in the nervous system itself. Your brain and spinal cord amplify pain signals, creating widespread discomfort that conventional pain medications can’t effectively address.
The condition involves multiple interconnected symptoms beyond pain. Profound fatigue persists regardless of sleep duration, leaving you exhausted even after full nights of rest. Cognitive difficulties—often called “fibro fog”—disrupt concentration, memory, and mental clarity. Sleep disturbances prevent restorative sleep despite exhaustion. Morning stiffness, headaches, and irritable bowel symptoms commonly accompany the core pain and fatigue.
Central sensitization represents the core mechanism driving fibromyalgia. Your nervous system becomes hypersensitive, amplifying normal sensory input into pain signals. Touch that should feel neutral becomes painful. Activities that shouldn’t cause discomfort create widespread aching. This isn’t imagined or exaggerated pain—it’s your nervous system genuinely perceiving pain from stimuli that wouldn’t hurt most people.
The psychological impact compounds physical suffering. Depression develops in the majority of fibromyalgia patients, whether from chronic pain itself or shared biological mechanisms. Anxiety about symptom flares and treatment failures creates constant worry. Social isolation increases as pain, fatigue, and unpredictability limit activities and relationships. The cumulative burden of managing multiple symptoms while appearing fine to others proves emotionally exhausting.
No single medication addresses all fibromyalgia symptoms, and treatments that help some patients prove ineffective for others. The FDA-approved medications—duloxetine, milnacipran, and pregabalin—provide meaningful relief for only 30-50% of patients. Even those who respond often experience incomplete improvement, with persistent pain and fatigue despite treatment.
Traditional pain medications work poorly for fibromyalgia because they target tissue damage or inflammation rather than central nervous system pain amplification. Opioids provide minimal benefit for fibromyalgia pain while carrying significant risks of dependence and worsening pain sensitivity over time. Anti-inflammatory medications like NSAIDs offer little relief because fibromyalgia doesn’t involve inflammatory processes.
Gabapentinoids such as pregabalin and gabapentin calm overactive nerves and help some patients but leave many with inadequate relief or intolerable side effects like sedation and weight gain. Antidepressants including duloxetine and amitriptyline address both pain and mood but work for only a subset of patients and often cause dry mouth, sexual dysfunction, or other side effects limiting long-term use.
The trial-and-error nature of fibromyalgia treatment creates treatment fatigue. After years of trying multiple medications, physical therapy approaches, lifestyle modifications, and alternative treatments with limited success, many patients feel hopeless about finding meaningful relief. The unpredictability of what will work for whom makes treatment planning particularly challenging.
Multiple symptoms requiring multiple interventions means no single treatment addresses everything. Medication for pain doesn’t resolve fatigue. Sleep aids don’t improve cognitive difficulties. Exercise helps but proves difficult when pain and exhaustion dominate. This complexity requires comprehensive, multi-modal treatment approaches rather than single solutions.
Ketamine addresses fibromyalgia through NMDA receptor antagonism, blocking the receptors critically involved in central sensitization. This mechanism targets the nervous system hypersensitivity underlying fibromyalgia pain rather than treating peripheral tissue damage. By interrupting pain amplification pathways in the spinal cord and brain, ketamine can reduce the widespread pain characteristic of fibromyalgia.
NMDA receptors play a central role in how your nervous system develops and maintains chronic pain states. In fibromyalgia, these receptors contribute to the wind-up phenomenon where pain signals amplify through repeated activation. Ketamine’s blockade prevents this sensitization and may help reduce already-established nervous system hypersensitivity.
Ketamine also addresses neuroinflammation in the central nervous system, reducing production of inflammatory mediators that maintain pain pathways. Depression commonly co-occurring with fibromyalgia responds to ketamine’s rapid antidepressant effects, addressing multiple dimensions of the condition simultaneously.
However, the evidence for ketamine in fibromyalgia requires honest discussion. Research shows short-term pain reduction—lasting hours to days after infusions—but long-term efficacy remains less established than for other conditions ketamine treats. Studies reveal mixed results, with some patients experiencing significant improvement while others notice minimal benefit. The evidence base is smaller and less conclusive than for depression, PTSD, or neuropathic pain.
Case studies suggest that higher ketamine doses, longer infusion durations, and more frequent treatments may produce better outcomes than the single low-dose infusions tested in early research. This aligns with clinical experience showing that fibromyalgia often requires more intensive ketamine protocols than other conditions. Individual variation in response remains high—predicting who will benefit proves difficult before trying treatment.
The preliminary nature of evidence means ketamine for fibromyalgia represents an experimental approach for treatment-resistant cases rather than established first-line therapy. We’re transparent about both the potential benefits and the limitations current research reveals.
Our fibromyalgia treatment uses IV ketamine delivered over 2-4 hours under continuous medical monitoring. Extended infusions allow sustained NMDA receptor blockade that appears more effective for fibromyalgia than shorter protocols. Your Board Certified CRNA ensures both therapeutic benefit and medical safety throughout these longer sessions.
Initial protocols typically involve 4-6 infusions scheduled 1-2 times weekly, though fibromyalgia often requires more individualized scheduling than other conditions. Some patients need additional treatments in the initial series to achieve meaningful improvement. Dosing may be higher than for depression or anxiety, with careful titration based on your response and side effects.
During treatment, you’ll experience dissociation, altered perception, and deep relaxation. These effects are temporary and resolve within 1-2 hours after infusion ends. Many patients describe profound relief during sessions, though the key question is how long benefits persist afterward.
Maintenance infusions are essential for sustained benefit in fibromyalgia. Unlike depression where some patients maintain improvement after initial treatment, fibromyalgia typically requires ongoing infusions to prevent pain from returning. Maintenance frequency varies—some patients need monthly treatments while others require more frequent sessions. This isn’t treatment failure but reflects fibromyalgia’s persistent nature.
Body-centered work during ketamine sessions proves particularly valuable for fibromyalgia. Central sensitization involves both biological pain amplification and learned patterns of tension, guarding, and stress responses. Somatic facilitation helps you work with physical sensations, regulate your nervous system, and process the mind-body dimensions of fibromyalgia.
During sessions, you’ll focus on breath, movement, and awareness of bodily sensations while ketamine reduces pain amplification. This allows exploration of how stress, tension, and psychological factors interact with your physical symptoms. You’ll learn regulation skills that help distinguish pain signals from muscle tension, recognize when anxiety amplifies pain perception, and develop new responses to pain that reduce its intensity and impact.
Fibromyalgia exists at the intersection of biology and psychology—neither purely physical nor purely mental. Somatic work addresses this integration, complementing ketamine’s neurological effects with attention to the behavioral and psychological patterns maintaining symptoms.
Ketamine works best as part of comprehensive fibromyalgia management rather than standalone treatment. Our psychiatric medication expertise ensures your existing medications—whether duloxetine, pregabalin, or others—are optimally dosed and coordinated with ketamine therapy. We address depression, sleep problems, and anxiety that commonly accompany fibromyalgia.
As ketamine provides relief, we can often reduce medications with troublesome side effects or adjust regimens for better overall symptom control. Many patients benefit from combining ketamine with appropriate long-term medications, addressing fibromyalgia through multiple mechanisms simultaneously.
For ongoing symptom management between IV treatments, ketamine troches provide at-home relief. These prescription oral ketamine lozenges offer flexibility for maintaining pain control without requiring frequent clinic visits. Many patients use troches as a bridge between IV infusions or transition to troches for long-term maintenance after completing their initial IV series.
Honesty about what ketamine can achieve for fibromyalgia matters for realistic expectations and treatment satisfaction. Research and clinical experience reveal highly variable results compared to other conditions ketamine treats. Some patients experience significant improvement—50% or more pain reduction, better energy, improved function. Some notice modest benefits that make symptoms more manageable without dramatic change. Some experience minimal or no relief despite completing full treatment protocols.
Short-term pain reduction during and immediately after infusions occurs more consistently than sustained long-term benefit. Many patients feel substantially better during the hours or days following treatment, with effects gradually diminishing over subsequent weeks. This pattern differs from depression, where improvement often persists for extended periods after initial treatment.
Predicting who will respond remains challenging. No clear markers identify good candidates versus those unlikely to benefit. Factors like symptom severity, duration of illness, previous treatments tried, and psychological factors don’t reliably predict ketamine response in fibromyalgia. The only way to know if you’ll benefit is trying treatment while maintaining realistic expectations.
The research base for ketamine in fibromyalgia is smaller and less conclusive than for depression, PTSD, or neuropathic pain. Studies show promise but also highlight significant individual variation and the limitations of available evidence. Larger, longer-term trials are needed to definitively establish ketamine’s role in fibromyalgia treatment.
Realistic expectations center on ketamine as one component of comprehensive fibromyalgia management, not a cure or standalone solution. Benefits typically require ongoing maintenance treatment. Improvement usually means better symptom management rather than complete resolution. Success involves reduced pain intensity, improved function, and better quality of life despite persistent symptoms.
You may benefit from ketamine therapy for fibromyalgia if FDA-approved medications provide inadequate relief or intolerable side effects, your symptoms significantly impact daily functioning and quality of life, you’re willing to commit to initial treatment series and likely ongoing maintenance, you understand this represents an experimental approach with variable results, or you’re seeking comprehensive multi-modal treatment rather than single-solution approaches.
Ketamine is not first-line fibromyalgia treatment. You should have tried standard approaches first including medications like duloxetine, milnacipran, or pregabalin, regular exercise programs appropriate for fibromyalgia, sleep hygiene and sleep disorder treatment, and stress management or psychological approaches. Ketamine serves best when conventional treatments have been inadequate.
Medical clearance ensures you’re safe for ketamine treatment. Uncontrolled cardiovascular disease requires optimization before proceeding. Active substance use disorders need addressing prior to ketamine therapy. Certain psychiatric conditions require careful evaluation. We review your complete medical history to ensure ketamine is appropriate for your situation.
Treatment commitment matters for fibromyalgia. You’ll need ability to attend regular appointments during initial treatment and maintenance, transportation home after each infusion, adequate support system during your treatment course, realistic expectations about variable results, and willingness to combine ketamine with other management approaches. Success requires active participation in comprehensive fibromyalgia care rather than passive receipt of single treatments.
Fibromyalgia creates exhausting challenges that resist conventional treatment approaches. While ketamine therapy doesn’t work for everyone and requires ongoing commitment, it offers hope for some patients when other treatments have failed. Our comprehensive approach combines evidence-based ketamine protocols with body-centered support and medication management, all delivered with anesthesia-level safety standards and genuine understanding of what fibromyalgia demands. Schedule a consultation to explore new possibilities for relief through a comprehensive, evidence-based approach.
[1] Hah, J. M., et al. (2021). “Systematic Review of the Use of Intravenous Ketamine for Fibromyalgia.” Pain Medicine, 22(11), 2659-2668. https://pmc.ncbi.nlm.nih.gov/articles/PMC8675611/
[2] Louzada-Junior, P., et al. (2024). “Ketamine in fibromyalgia: a systematic review.” Advances in Rheumatology, 64(1), 53. https://advancesinrheumatology.biomedcentral.com/articles/10.1186/s42358-024-00393-9
Conditions Treated
1201 U.S. Highway 10 W, Unit A4, Livingston 59047
Mend The Mind is a psychiatric practice in Livingston, Montana, specializing in ketamine therapy and comprehensive mental health services for adults. With anesthesia expertise ensuring the highest safety standards, we bring evidence-based treatment to rural Montana communities.